Secretion of cytokines and growth factors as a general cause of constitutive NFκB activation in cancer

Oncogene

Volumn 23, Issue 12, 2004, Pages 2138-2145

  Lu, Tao ^a   Sathe, Swati S ^a   Swiatkowski, Shannon M ^a   Hampole, Chetan V ^a   Stark, George R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ELISA; FGF5; Microarrays; Mutant 293 cells; TGF 2

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA2; GROWTH PROMOTOR;

ARTICLE; CANCER; CARCINOGENESIS; CELL ASSAY; CELL MUTANT; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; MALE; MARKER GENE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN SECRETION; REPORTER GENE; TUMOR CELL LINE; CULTURE MEDIUM; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM; MUTATION; NEOPLASM; SECRETION; TRANSACTIVATION;

CELL LINE, TUMOR; CULTURE MEDIA, CONDITIONED; CYTOKINES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GROWTH SUBSTANCES; HELA CELLS; HUMANS; MUTATION; NEOPLASMS; NF-KAPPA B; TRANS-ACTIVATION (GENETICS);

EID: 1842538759     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207332     Document Type: Article

References (56)

1. Alitalo K and Carmeliet P. (2002). Cancer Cell, 1, 219-227.
2. Arlt A, Vorndamm J, Muerkoster S, Yu H, Schmidt WE, Folsch UR and Schafer H. (2002). Cancer Res., 62, 910-916.
3. Baeuerle PA and Henkel T. (1994). Annu. Rev. Immunol., 12, 141-179.
4. Baldwin AS. (2001). J. Clin. Invest., 107, 241-246.
5. Bhat-Nakshatri P, Sweeney CJ and Nakshatri H. (2002). Oncogene, 21, 2066-2078.
6. Brach MA, Henschler R, Mertelsmann RH and Herrmann F. (1991). Pathobiology, 59, 284-288.
7. Brown JM, Corey E, Lee ZD, True LD, Yun TJ, Tondravi M and Vessella RL. (2001). Urology, 57, 611-616.
8. Byrd VM, Ballard DW, Miller GG and Thomas JW. (1999). J. Immunol., 162, 5853-5859.
9. Chen T, Carter D, Garrigue-Antar L and Reiss M. (1998). Cancer Res., 58, 4805-4810.
10. Chen T, de Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A and Reiss M. (1999). Int. J. Cancer, 82, 43-51.
11. Clauss M. (2000). Semin. Thromb. Hemost., 26, 561-569.
12. Coussens LM and Werb Z. (2001). J. Exp. Med., 193, 727-740.
13. Coward WR, Okayama Y, Sagara H, Wilson SJ, Holgate ST and Church MK. (2002). J. Immunol., 169, 5287-5293.
14. Deng J, Miller SA, Wang HY, Xia W, Wen Y, Zhou BP, Li Y, Lin SY and Hung MC. (2002). Cancer Cell, 2, 323-334.
15. Furudoi A, Tanaka S, Haruma K, Kitadai Y, Yoshihara M, Chayama K and Shimamoto F. (2002). Oncology, 62, 157-166.
16. Furuta K, Misao S, Takahashi K, Tagaya T, Fukuzawa Y, Ishikawa T, Yoshioka K and Kakumu S. (1999). Int. J. Cancer, 81, 851-853.
17. Galibert L, Tometsko ME, Anderson DM, Cosman D and Dougall WC. (1998). J. Biol. Chem., 273, 34120-34127.
18. Giri DK and Aggarwal BB. (1998). J. Biol. Chem., 273, 14008-14014.
19. Held-Feindt J and Mentlein R. (2002). Int. J. Cancer, 98, 352-356.
20. Hermouet S, Corre I and Lippert E. (2000). Leuk. Lymphoma, 38, 39-48.
21. Hishima T, Fukayama M, Hayashi Y, Fujii T, Ooba T, Funata N and Koike M. (2000). Am. J. Surg. Pathol., 24, 742-746.
22. Iacopetta BJ, Soong R, House AK and Hamelin R. (1999). J. Pathol., 187, 428-432.
23. Kacinski BM. (1995). Ann. Med, 27, 79-85.
24. Karkkainen MJ, Makinen T and Alitalo K. (2002). Nat. Cell Biol., 4, E2-E5.
25. Karkkainen MJ and Petrova TV. (2000). Oncogene, 19, 5598-5605.
26. Kascinski B. (2002). Cancer Treat. Res., 107, 285-292.
27. Klomp HJ, Zernial O, Flachmann S, Wellstein A and Juhl H. (2002). Clin. Cancer Res., 8, 823-827.
28. Kornmann M, Ishiwata T, Beger HG and Korc M. (1997). Oncogene, 15, 1417-1424.
29. Koubek K, Stary J, Kumberova A, Klamova H and Filipec M. (1999). Eur. J. Haematol, 63, 1-10.
30. Li JM, Shen X, Hu PP and Wang XF. (1998). Mol. Cell. Biol., 18, 110-121.
31. Lu T, Burdelya LG, Swiatkowski SM, Boiko AD, Howe PH, Stark GR and Gudkov AV, manuscript submitted.
32. Mattila MM, Ruohola JK, Karpanen T, Jackson DG, Alitalo K and Harkonen PL. (2002). Int. J. Cancer, 98, 946-951.
33. McDermott RS, Deneux L, Mosseri V, Vedrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X, Beuzeboc P, Pouillart P and Scholl SM. (2002). Eur. Cytokine Network, 13, 121-127.
34. Mentlein R and Held-Feindt J. (2002). J. Neurochem., 83, 747-753.
35. Michigami T, Ihara-Watanabe M, Yamazaki M and Ozono K. (2001). Cancer Res., 61, 1637-1644.
36. Miyaki M, Iijima T, Konishi M, Sakai K, Ishii A, Yasuno M, Hishima T, Koike M, Shitara N, Iwama T, Utsunomiya J, Kuroki T and Mori T. (1999). Oncogene, 18, 3098-3103.
37. Mizukami J, Takaesu G, Akatsuka H, Sakurai H, Ninomiya-Tsuji J, Matsumoto K and Sakurai N. (2002). Mol. Cell. Biol., 22, 992-1000.
38. O'Connell MA, Cleere R, Long A, O'Neill LA and Kelleher D. (1995). J. Biol. Chem., 270, 7399-7404.
39. O'Neill LA. (2002). Mol. Cell, 10, 969-971.
40. Pahl HL. (1999). Oncogene, 18, 6853-6866.
41. Romieu-Mourez R, Landesman-Bollag E, Seldin DC and Sonenshein GE. (2002). Cancer Res., 62, 6770-6778.
42. Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E and Mariette X. (2002). Am. J. Clin. Pathol., 117, 210-216.
43. Sapi E and Kacinski BM. (1999). Proc. Soc. Exp. Biol. Med., 220, 1-8.
44. Sathe SS, Sizemore N, Li X, Vithalani K, Commane M, Swiatkowski SM and Stark GR, manuscript submitted.
45. Schiemann WP, Pfeifer WM, Levi E, Kadin ME and Lodish HF. (1999). Blood, 94, 2854-2861.
46. Sezer O, Heider U, Jakob C, Zavrski I, Eucker J, Possinger K, Sers C and Krenn V. (2002). Blood, 99, 4646-4647.
47. Siebenlist U, Franzoso G and Brown K. (1994). Annu. Rev. Cell Biol., 10, 405-455.
48. Sizemore N, Lerner N, Dombrowski N, Sakurai H and Stark G. (2002). J. Biol. Chem., 277, 3863-3869.
49. Takahashi A, Kono K, Itakura J, Amemiya H, Feng TR, Iizuka H, Fujii H and Matsumoto Y. (2002). Oncology, 62, 121-127.
50. Ueda M, Terai Y, Yamashita Y, Kumagai K, Ueki K, Yamaguchi H, Akise D, Hung YC and Ueki M. (2002). Int. J. Cancer, 98, 335-343.
51. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D and Miyamoto S. (1995). Genes Dev., 9, 2723-2735.
52. Wolf JS, Chen Z, Dong G, Sunwoo JB, Bancroft CC, Capo DE, Yeh NT, Mukaida N and Van Waes C. (2001). Clin. Cancer Res., 7, 1812-1820.
53. Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F and Boyce BF. (2002). J. Bone Miner. Res., 17, 1200-1210.
54. Yamamoto H, Kishimoto T and Minamoto S. (1998). J. Immunol., 161, 4753-4759.
55. Yonemura Y, Endo Y, Fujita H, Fushida S, Niriomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K and Sasaki T. (1999). Clin. Cancer Res., 5, 1823-1829.
56. Zhang N, Zhong R and Deuel TF. (1999). J. Biol. Chem., 274, 12959-12962.